E
Sell
3/14/2023Downgrade
NexImmune, Inc. (NEXI) was downgraded to E+ from D- on 03/14/2023.
D
Sell
2/23/2023Upgraded
NexImmune, Inc. (NEXI) was upgraded to D- from E+ on 2/23/2023 due to an increase in the volatility index.
E
Sell
2/8/2023Downgrade
NexImmune, Inc. (NEXI) was downgraded to E+ from D- on 2/8/2023 due to a decline in the volatility index, solvency index and total return index. The quick ratio declined from 5.83 to 4.88.
D
Sell
5/31/2022Upgraded
NexImmune, Inc. (NEXI) was upgraded to D- from E+ on 5/31/2022 due to an increase in the total return index and volatility index.
E
Sell
5/13/2022Downgrade
NexImmune, Inc. (NEXI) was downgraded to E+ from D- on 5/13/2022 due to a decline in the solvency index. The quick ratio declined from 11.34 to 9.17.
D
Sell
5/5/2022Upgraded
NexImmune, Inc. (NEXI) was upgraded to D- from E+ on 5/5/2022 due to an increase in the volatility index and valuation index.
E
Sell
4/20/2022Downgrade
NexImmune, Inc. (NEXI) was downgraded to E+ from D- on 4/20/2022 due to a decline in the valuation index.
D
Sell
3/15/2022Upgraded
NexImmune, Inc. (NEXI) was upgraded to D- from E+ on 3/15/2022 due to an increase in the growth index.
E
Sell
2/16/2022Downgrade
NexImmune, Inc. (NEXI) was downgraded to E+ from D- on 2/16/2022 due to a major decline in the efficiency index, solvency index and volatility index. The quick ratio declined from 18.75 to 12.55, net income declined 20.23% from -$12.18M to -$14.65M, and total capital declined 12.32% from $110.75M to $97.11M.
D
Sell
11/3/2021Upgraded
NexImmune, Inc. (NEXI) was upgraded to D- from E on 11/3/2021 due to an increase in the growth index and volatility index. Earnings per share increased from -$0.7064 to -$0.5388.
E
Sell
8/2/2021Upgraded
NexImmune, Inc. (NEXI) was upgraded to E from E- on 8/2/2021 due to an increase in the valuation index.
E
Sell
5/18/2021None
NexImmune, Inc. (NEXI) was downgraded to E- from U on 05/18/2021.
